You have 9 free searches left this month | for more free features.

nasal type

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Extranodal NK/T Cell Lymphoma, Nasal Type Trial in Guangdong (IBI318(Recombinant human anti-PD1/PD-L1 bispecific antibody))

Active, not recruiting
  • Extranodal NK/T Cell Lymphoma, Nasal Type
  • IBI318(Recombinant human anti-PD1/PD-L1 bispecific antibody)
  • Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 10, 2022

Lymphoma Trial (Tislelizumab)

Not yet recruiting
  • Lymphoma
  • (no location specified)
Jul 28, 2022

Type 1 Diabetes, Diabetes, Type 1 Trial in Australia (Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®), Abatacept (CTLA4-Ig)

Recruiting
  • Type 1 Diabetes
  • Diabetes Mellitus, Type 1
  • Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®)
  • Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride)
  • Westmead, New South Wales, Australia
  • +5 more
Feb 15, 2023

Chronic Rhinosinusitis With Nasal Polyps Trial in Kafrelsheikh (Budesonide, Prednisone, Saline)

Completed
  • Chronic Rhinosinusitis With Nasal Polyps
  • Kafrelsheikh, Egypt
    Kafrelsheikh University hospital
Jul 3, 2023

Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type, Early-stage, High-Risk Cancer Trial in Beijing (Anti-PD-1 mAb,

Recruiting
  • Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
  • +2 more
  • Anti-PD-1 monoclonal antibody
  • +4 more
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Feb 23, 2022

Hypoglycemia Unawareness, Type 1 Diabetes Trial in Minneapolis (intra-nasal naloxone, Intra-nasal saline)

Terminated
  • Hypoglycemia Unawareness
  • Type 1 Diabetes
  • intra-nasal naloxone
  • Intra-nasal saline
  • Minneapolis, Minnesota
    Clinical and Translational Science Institute, University of Minn
Sep 26, 2022

Early-stage, Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Trial in Beijing (Anti-PD-1 mAb)

Recruiting
  • Early-stage
  • Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
  • Anti-PD-1 monoclonal antibody
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Dec 7, 2021

Efficiency of HFNC Vs NIV in Patient With Acute Type 2 RF

Completed
  • Type 2 Respiratory Failure
    • Banī Suwayf, Bani Suwayf, Egypt
      Faculty of medicine
    Jan 22, 2023

    Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, Early Stage, Anlotinib Trial in Guangzhou (Sintilimab)

    Completed
    • Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
    • +7 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Jun 6, 2022

    Extranodal NK/T-cell Lymphoma, Nasal Type Trial in Shanghai (Methotrexate, Etoposide, Dexamethasone)

    Active, not recruiting
    • Extranodal NK/T-cell Lymphoma, Nasal Type
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Aug 19, 2021

    Central Insulin Resistance, Diabetes, Type 2, PreDiabetes Trial (Human nasal insulin, Placebo)

    Not yet recruiting
    • Central Insulin Resistance
    • +2 more
    • Human nasal insulin
    • Placebo
    • (no location specified)
    May 12, 2023

    Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Trial in Shanghai (Anlotinib)

    Completed
    • Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
    • Shanghai, China
      Xinhua Hospital
    Sep 13, 2021

    Viral and Epigenetic Influences in CRSwNP

    Recruiting
    • Chronic Rhinosinusitis (Diagnosis)
    • Endoscopic sinus surgery (ESS)
    • Montréal, Quebec, Canada
      CHUM
    May 19, 2023

    COVID-19, Influenza A, Influenza Type B Trial in Nashville (Panbio™)

    Recruiting
    • COVID-19
    • +2 more
    • Panbio™
    • Nashville, Tennessee
      UCCT @ Complete Health Partners- Nashville
    Dec 21, 2022

    Type 1 Diabetes Trial in United States (Glucagon Nasal Powder [Baqsimi])

    Recruiting
    • Type 1 Diabetes
    • Glucagon Nasal Powder [Baqsimi]
    • Los Angeles, California
    • +8 more
    Apr 6, 2022

    Chronic Disease, Nasal Polyposis, Rhinitis Trial in Trondheim (botox injection Multiguide)

    Completed
    • Chronic Disease
    • +2 more
    • botox injection Multiguide
    • Trondheim, Norway
      St Olavs Hospital
    Oct 29, 2021

    Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Classical Hodgkin Lymphoma Trial in Houston (CD30.CAR-EBVST cells)

    Recruiting
    • Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
    • Classical Hodgkin Lymphoma
    • CD30.CAR-EBVST cells
    • Houston, Texas
    • +1 more
    Jul 20, 2022

    Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Trial in Shanghai (tislelizumab, azacytidine, lenalidomide, tislelizumab,

    Recruiting
    • Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
    • tislelizumab, azacytidine, lenalidomide
    • tislelizumab, etoposide, pegaspargase
    • Shanghai, Shanghai, China
      Xinhua Hospital,Shanghai Jiao Tong University School of Medicine
    Sep 17, 2021

    Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by

    Not yet recruiting
    • Adult T-cell Leukemia/Lymphoma
    • +4 more
    • CC-486 (5-azacitidine)
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Lymphoma Trial in Philadelphia (Pembrolizumab)

    Withdrawn
    • Lymphoma
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    May 5, 2021

    Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)

    Completed
    • Peripheral T Cell Lymphoma
    • +18 more
    • Vancouver, British Columbia, Canada
    • +29 more
    Apr 29, 2022

    Sialolithiasis Trial in Seoul (nasotracheal tube (Ring-Adair-Elwin), nasotracheal tube (portex))

    Recruiting
    • Sialolithiasis
    • nasotracheal tube (Ring-Adair-Elwin)
    • nasotracheal tube (portex)
    • Seoul, Korea, Republic of
      Gangnam Severance Hospital
    Mar 16, 2022

    Diabetes, Type 1, Hypoglycemia, Hypoglycemia Unawareness Trial in Bronx (Naloxone, Diazoxide, Placebo (for Naloxone))

    Suspended
    • Diabetes Mellitus, Type 1
    • +2 more
    • Bronx, New York
      Albert Einstein College of Medicine
    Feb 3, 2022

    COVID-19, Influenza A, Influenza Type B Trial in Easley (Nasal and Nasopharyngeal Sampling of the Panbio™ COVID-19/ Flu A&B

    Recruiting
    • COVID-19
    • +2 more
    • Nasal and Nasopharyngeal Sampling of the Panbio™ COVID-19/ Flu A&B Rapid Panel
    • Easley, South Carolina
      Urgent Care Clinical Trials Easley
    Apr 28, 2022

    Extranodal Lymphoma or Lymphoma of Rare Pathological Types

    Not yet recruiting
    • Lymphoma
    • +8 more
    • No interventions need to be specified for this study
    • Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Jun 15, 2023